SAFC completes Jerusalem fermentation plant expansion

This content item was originally published on www.biopharma-reporter.com, a William Reed online publication.

By Gareth Macdonald and Claire Videau

- Last updated on GMT

SAFC has completed the expansion of its manufacturing plant in Jerusalem, Israel, further increasing its global footprint.

In an exclusive video interview, SAFC president Gilles Cottier and VP of contract manufacturing services Mark Cassidy told in-Pharmatechnologist that growing industry demand for high potency active pharmaceutical ingredients (APIs) was the key driver for the investment.

Cottier also explained that the addition of such capability is an important part of differentiating SAFC's offering in the increasingly competitive global contract manufacturing sector

The 50,000 expansion includes capacity for bulk drugs, secondary metabolites, cytotoxins and a range of large molecules proteins. SAFC has also installed additional

Related news

Show more

Related product

Understanding the hidden value of quality

Understanding the hidden value of quality

Content provided by Thermo Fisher Scientific – Production Chemicals and Services | 16-Jan-2023 | White Paper

The raw material supply is too vital to leave to chance, and quality-related supply chain activities are cornerstones to your success.

Follow us

Products

View more

Webinars